EDGAR Filing Documents for 0001144204-14-055174

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001144204-14-055174

Filing Date

2014-09-10

Accepted

2014-09-10 14:59:46

Documents

Effectiveness Date

2014-09-10

Items

Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	8914
	Complete submission text file	0001144204-14-055174.txt		10079

Mailing Address 158-160 NORTH GOWER STREET LONDON X0 NW1 2ND

Business Address 158-160 NORTH GOWER STREET LONDON X0 NW1 2ND 44 207 932 2100

Advent Life Sciences Fund II LP (Filer) CIK: 0001614918 (see all company filings)